Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashley Irish

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 10, 2025
Safety and Efficacy of MV140 Sublingual Vaccine (Uromune) in Preventing Recurrent Urine Infections Post Renal Transplant: A Case SeriesBenjamin Palladino, Devin O'Shea-Farren, Peter Boan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 31, 2007
Anemia after kidney transplantation is not completely explained by reduced kidney functionSteven J Chadban, Laura Baines, Kevan Polkinghorne, et al.
Journal of Hypertension|August 26, 2009
The effects of [omega]3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trialTrevor A Mori, Valerie Burke, Ian Puddey, et al.
Journal of Medical Virology|February 5, 2020
Cytomegalovirus burden improves a predictive model identifying measures of vascular risk in renal transplant recipients and healthy adultsJacquita S Affandi, Silvia Lee, HuiJun Chih, et al.
International Journal of Molecular Sciences|November 11, 2022
Variants of HCMV <i>UL18</i> Sequenced Directly from Clinical Specimens Associate with Antibody and T-Cell Responses to HCMVShelley Waters, Silvia Lee, Ibnu Ariyanto, et al.
Human Immunology|December 1, 2022
Do variations in the HLA-E ligand encoded by UL40 distinguish individuals susceptible to HCMV disease?Shelley Waters, Richard J N Allcock, Silvia Lee, et al.
The Medical Journal of Australia|October 15, 2023
Improving equity in access to kidney transplantation: implementing targeted models of care focused on improving timely access to waitlistingKatie Cundale, Stephen P McDonald, Ashley Irish, et al.
Clinical Transplants|March 28, 2008
HLA antibodies and soluble CD30 are associated with poor renal graft outcome: updated results of a single-center cross-sectional studyLeanne L Langan, Lloyd D'Orsogna, Lawrence P Park, et al.
Plos One|July 26, 2022
Prediction models used in the progression of chronic kidney disease: A scoping reviewDavid K E Lim, James H Boyd, Elizabeth Thomas, et al.
Nephrology (Carlton, Vic.)|March 12, 2004
Recommendations for the use of icodextrin in peritoneal dialysis patientsDavid W Johnson, John Agar, John Collins, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 10, 2025
Safety and Efficacy of MV140 Sublingual Vaccine (Uromune) in Preventing Recurrent Urine Infections Post Renal Transplant: A Case SeriesBenjamin Palladino, Devin O'Shea-Farren, Peter Boan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 31, 2007
Anemia after kidney transplantation is not completely explained by reduced kidney functionSteven J Chadban, Laura Baines, Kevan Polkinghorne, et al.
Journal of Hypertension|August 26, 2009
The effects of [omega]3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trialTrevor A Mori, Valerie Burke, Ian Puddey, et al.
Journal of Medical Virology|February 5, 2020
Cytomegalovirus burden improves a predictive model identifying measures of vascular risk in renal transplant recipients and healthy adultsJacquita S Affandi, Silvia Lee, HuiJun Chih, et al.
International Journal of Molecular Sciences|November 11, 2022
Variants of HCMV <i>UL18</i> Sequenced Directly from Clinical Specimens Associate with Antibody and T-Cell Responses to HCMVShelley Waters, Silvia Lee, Ibnu Ariyanto, et al.
Human Immunology|December 1, 2022
Do variations in the HLA-E ligand encoded by UL40 distinguish individuals susceptible to HCMV disease?Shelley Waters, Richard J N Allcock, Silvia Lee, et al.
The Medical Journal of Australia|October 15, 2023
Improving equity in access to kidney transplantation: implementing targeted models of care focused on improving timely access to waitlistingKatie Cundale, Stephen P McDonald, Ashley Irish, et al.
Clinical Transplants|March 28, 2008
HLA antibodies and soluble CD30 are associated with poor renal graft outcome: updated results of a single-center cross-sectional studyLeanne L Langan, Lloyd D'Orsogna, Lawrence P Park, et al.
Plos One|July 26, 2022
Prediction models used in the progression of chronic kidney disease: A scoping reviewDavid K E Lim, James H Boyd, Elizabeth Thomas, et al.
Nephrology (Carlton, Vic.)|March 12, 2004
Recommendations for the use of icodextrin in peritoneal dialysis patientsDavid W Johnson, John Agar, John Collins, et al.
Pageof 6